Conference icon

Conference

PROTECT-1: A prospective randomized trial of CCX282-B (Traficet-EN), a novel oral therapy targeting chemokine receptor 9 in Crohn's disease

Publication status:
Published

Actions


Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Experimental Medicine Division, Clinical Medicine
Role:
Author
Expand authors...
Volume:
102
Pages:
S475-S475
Publication date:
2007-09-05
ISSN:
0002-9270
URN:
uuid:d62f7a1f-2809-4023-9130-69fef667f7cd
Source identifiers:
66727
Local pid:
pubs:66727

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP